This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $42,270.40 delivery order is for the supply of Lynparza 150 mg tablets and is under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with the DLA that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $39,357.76 firm fixed price delivery order is for the pharmaceutical product Lynparza 100 mg tablets. The contract has an ultimate completion date of June 12, 2024. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This federal contract award is a Delivery Order valued at $10,567.60 made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYNPARZA 150 MG TABLET, a prescription medication, with a performance period through July 1, 2025. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Delivery Order for the medication LYNPARZA 150 MG TABLET UU 60S, with a ceiling value of $20,998.68 and a completion date of July 15, 2025. The contract is a Firm Fixed Price agreement and is not a set-aside. AmerisourceBergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $4,902.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply LYNPARZA 100 MG TABLET in 60-count units. No set-aside designation was used for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract, worth $10,519.62, is for the delivery of LYNPARZA 100 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of June 13, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a key supplier of medical and...
This is a $10,499.34 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of LYNPARZA 150 MG TABLET UU 60S. The award has an ultimate completion date of July 1, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which serves as a comprehensive global...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a $42,270.40 firm fixed price delivery order for the supply of 120 count bottles of the pharmaceutical drug LYNPARZA 150 MG TABLET. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,997.36 firm-fixed-price contract is for the supply of 60-count tablets of the prescription drug Lynparza (olaparib), a medication used to treat certain types of cancer. The contract has a completion date of May 6, 2025 and is not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LYNPARZA 150 MG TABLET UU 60S, a prescription medication, with a ceiling value of $10,499.34 and a period of performance through July 21, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite...